Board Structure

The board of directors is composed of seven members consisting of three directors and four independent directors. Independent directors have no ties to the company either through transactions or as a former employee or inside director.

  • Executive Vice President / John Rim
    President & CEO,
    Chairman of the board
    John Rim
    • President & CEO, Samsung Biologics (2020-Present)
    • Executive Vice President, CMO2 Center,
      Samsung Biologics
      (2018-2020)
    • Vice President, Global Product Development Procurement, Roche (2014-2018)
    • Vice President, CFO Global Product Development, Roche (2010-2013)
    Executive Vice President / John Rim
    • Date of first appointment : March 20, 2020
    • Term expiration : March 16, 2026
  • EXECUTIVE VICE PRESIDENT / Dong joong Kim
    EXECUTIVE VICE PRESIDENT
    Dong Joong Kim
    • Executive Vice President,
      Business Support Center, Samsung Biologics
      (2014-Present)
    • Head of Planning Support Team,
      Production Technology Institute,
      Samsung Electronics
      (2013-2014)
    EXECUTIVE VICE PRESIDENT / Dong joong Kim
    • Date of first appointment : August 10, 2016
    • Term expiration : March 28, 2025
  • EXECUTIVE VICE PRESIDENT / Kun Lo
    EXECUTIVE VICE PRESIDENT
    Kun Lo
    • Executive Vice President,
      EPCV Center, Samsung Biologics
      (2021~Present)
    • Head of DS Center, Samsung Biologics(2020~2021)
    • Head of New Business Division, Samsung Engineering(2013~2020)
    EXECUTIVE VICE PRESIDENT / Kun Lo
    • Date of first appointment : March 17, 2023
    • Term expiration : March 16, 2026
  • Independent director / Geunnyeong Heo
    Independent Director
    Geunnyeong Heo
    • Independent Director,
      Samsung Biologics
      (2019-Present)
    • Advisor, Pyeong An Lawfirm(2019-Present)
    • Presiding Judge,
      Seoul Central District Court
      (2004-2007)
    Independent director / Geunnyeong Heo
    • Date of first appointment : March 22, 2019
    • Term expiration : March 28, 2025
  • INDEPENDENT DIRECTOR / Eunice Kyonghee Kim
    Independent Director
    Eunice Kyonghee Kim
    • Independent Director, Samsung Biologics (2020-Present)
    • Professor, Law School, Ewha Women's University (2010-2021)
    • Vice president, International Association of Korean Lawyers (IAKL) (2008-Present)
    • Deputy-CEO and Chief Legal & Compliance Officer, Hana Financial Group, Inc. (2008-2010)
    Independent director / Eunice Kyunghee Kim
    • Date of first appointment : March 20, 2020
    • Term expiration : March 16, 2026
  • Independent director / Changwoo Lee
    Independent Director
    Changwoo Lee
    • Independent Director, Samsung Biologics(2022-Present)
    • Emeritus Faculty, Business School,
      Seoul National University
      (2019-Present)
    • Chairman of the Ethics Committee,
      Korean Accounting Standard Board
      (2020-Present)
    Independent director / Changwoo Lee
    • Date of first appointment : March 29, 2022
    • Term expiration : March 28, 2025
  • Independent Director / Seoung Hwan Suh
    Independent Director
    Seoung Hwan Suh
    • Current Professor Emeritus at Yonsei University(2024-Present)
    • 19th President, Yonsei University(2020-2024)
    • Minister for Ministry of Land, Infrastructure, and Transport(2013-2015)
    • 18th Korea Presidential Transition Committee, Committee Member of the Economics Division 2(2013)
    Independent Director / Seoung Hwan Suh
    • Date of first appointment : March 15, 2024
    • Term expiration : March 14, 2027

Appointment of Directors

Members of the board of directors are elected through a resolution of the general meeting of shareholders under the company’s articles of incorporation. Incumbent members may be reelected after the expiration of their terms.

  • Samsung Biologics shall have at least three but no more than ten directors and such directors shall be appointed at the general meeting of shareholders; provided, however, that at least three independent directors shall be appointed and the number of the independent directors shall account for at least a majority of the total number of directors.
  • A resolution for the election of directors shall be adopted by the affirmative votes of a majority of the shareholders present at the meeting, which shall also be at least 1/4 of the total number of issued and outstanding shares.
  • Any vacancy in the office of directors shall be filled at a general meeting of shareholders; provided, however, that if the number of directors does not fall below the number prescribed in Paragraph 1 of Article 29 in the Articles of Incorporation and there is no difficulty in the administration of business, the foregoing shall not be applicable.

Term of Office of Director

The term of office of directors shall end at the close of the ordinary general meeting of shareholders convened in respect to the last fiscal year within three years from their appointment.

Chairperson

The chairperson of the board of directors shall be appointed among the directors by a resolution of the board of directors.

Resolution of the BOD

The resolution of the board of directors shall be adopted in the attendance of a majority of the directors in the office and by the affirmative votes of a majority of the directors present at the meeting; provided, however, that a resolution of the board of directors on matters stipulated under Article 397-2 (Prohibition of Use of Corporate Opportunities and Assets) and Article 398 (Self-Dealing between Directors, etc. and the Company) of the Commercial Code shall be adopted by the affirmative votes of at least 2/3 of the directors in office.

Independence of Independent Directors

The Independent Director Candidate Nomination Committee shall nominate the candidates for the independent directors among persons who meet qualification requirements stipulated in the relevant laws and regulations, including the Commercial Code, etc.

  • An independent director shall be one with professional knowledge or sufficient experience in management, economics, accounting, law or relevant technology and duly qualified under the relevant law. He or she shall not be a current employee or director or a previous employee or director of the company or its affiliate (as stipulated in the Monopoly Regulation and Fair Trade Act) within the past two years, a major shareholder of the company or one with a special relationship with a major shareholder.

The board of directors shall be divided into an ordinary and extraordinary board.
In principle the chairperson convenes the board of directors meeting, and if it is deemed necessary for administration of business, any director may convene the board of directors meeting with the consent of the chairperson.

BOD Operation Rules PDF Download

Meetings of the BOD

The board of directors shall be divided into an ordinary and extraordinary board.

  • Ordinary Board of Directors : The meeting of ordinary board of directors is held once a quarter. The chairperson of the board of directors shall set the date and call for the meeting.
  • Extraordinary Board of Directors : The meeting of extraordinary board of directors may be held from time to time as required.

Convening of BOD Meeting

In principle the chairperson convenes the board of directors meeting, and if it is deemed necessary for administration of business, any director may convene the board of directors meeting with the consent of the chairperson.

  • Procedure : The chairperson shall set a date and time of the meeting of the board of directors and give a notice to each director no later than twenty four hours prior to the meeting in writing, electronic document, or orally; provided, however, that such notice may be waived with the unanimous consent of all directors.

Resolution of the BOD

The resolution of the board of directors shall be adopted in the attendance of a majority of the directors in office and by the affirmative votes of a majority of the directors present at the meeting.

  • The board of directors may allow all or a part of the directors who do not attend a meeting in person to participate in a resolution through communication that concurrently transmits and receives voices of all directors. In this case, such director shall be deemed to have attended the board of directors meeting in person.
  • A director with his or her own interests in a resolution of the board of directors shall not be allowed to participate in voting.

BOD Operation Rules

Article 1Purpose
Article 2Scope of Applications
  • With respect to matters pertaining to the BOD, these rules and regulations shall apply unless those stipulated otherwise in the relevant laws or the AOI.
Article 3Authority
  • The BOD shall deliberate and resolve matters stipulated in the relevant laws or the AOI, matters authorized by the general meeting of shareholders, and important issues concerning basic policies and execution of business related to the management of the Company.
  • The BOD shall supervise the directors’ execution of duty.
  • When it is determined that a director has violated a provision of the laws or the AOI in performing his/her duties, or performed such duties in a substantially improper manner, or the BOD recognizes that there is a concern that such director will perform his/ her duties in a substantially improper manner, the BOD may request such director to submit relevant data, cooperate on investigation, and/or provide explanation.
  • If any of the events in Paragraph 3 occurs, the BOD may require the relevant director to suspend or change the performance of relevant duties.
  • Any director may request the representative director to report performance of other directors or employees to the BOD.
Article 4Composition
  • The BOD shall be comprised of all directors.
  • The term of office of a director shall expire at the close of the ordinary general meeting of shareholders held for the third fiscal period from the inauguration of the applicable director.
Article 5Chairperson
  • The chairperson of the BOD shall be appointed among the directors by a resolution of the BOD.
  • The term of office of the chairperson shall end at the expiration of the term of office of the applicable director.
  • When the chairperson is unable to perform his/her duties, the director that was first appointed among all of the directors of the BOD shall act as the chairperson; provided, however, that if two (2) or more directors were appointed on the same date, the most senior director shall act as the chairperson.
Article 6Convening of BOD Meeting
  • The meetings of the BOD shall be either ordinary meetings or extraordinary meetings.
  • Ordinary meetings of the BOD shall, in principle, be convened once each quarter.
  • Extraordinary meetings of the BOD shall be convened on an ad-hoc basis when deemed necessary.
  • The chairperson of the BOD shall set a date and time of the meeting of the BOD, and provide written, electronic, or oral notice to each director no later than 24 hours in advance of such meeting; provided, however, that such convocation procedure may be omitted upon unanimous consent of the directors.
  • If it is deemed necessary for carrying out the business of the Company, any director may convene a meeting of the BOD upon the consent of the chairperson. In this case, the provisions in Paragraph 4 above shall apply mutatis mutandis.
Article 7Method of Resolution
  • Unless stipulated otherwise in the relevant laws and regulations, the BOD resolutions shall be done in accordance with Paragraphs 1 through 3 of Article 38 of the AOI.
  • Unless stipulated otherwise in the relevant laws and regulations, the number of directors who cannot exercise his/her vote in accordance with Article 38, Paragraph 3 of the AOI shall not be included in the number of directors present at the meeting.
Article 8Agenda
  • The following matters shall be resolved by the BOD:
    • 1.Convening of the general meeting of shareholders and matters for resolution to be submitted thereto
      【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
      • 1)Convening of the general meeting of shareholders
      • 2)Approval of financial statements
      • 3)Approval of annual report
      • 4)Distribution of profits
      • 5)Amendment to the AOI
      • 6)Capital reduction
      • 7)Dissolution, amalgamation, spin-off, merger through spin-off, continuation of company (Article 519 of the Commercial Code)
      • 8)Assignment of the businesses of the Company in whole or in material part; acquisition in whole or in part of another company’s business having a material impact on the business of the Company
      • 9)Lease or entrustment of management business in whole; execution of contract where all profits and losses are shared with a 3rd party (each a “Shared Contract”); execution, amendment, or termination of another contract that is commensurate to a Shared Contract
      • 10)Ex-post incorporation
      • 11)Appointment and dismissal of directors
      • 12)Remuneration of directors
      • 13)Issuance of shares at less-than-face value
      • 14)Acquisition of treasury shares
      • 15)Decision on stock dividends
      • 16)Stock-split and stock-consolidation of shares
      • 17)Waiver of a director’s liability toward the Company upon unanimous consent of the shareholders
      • 18)Redemption of shares
      • 19)Total share swap
      • 20)Total share transfer
      • 21)Granting of stock options
      • 22)Other agenda items to be submitted to the general meeting of shareholders and material issues concerning shares
    • 2.Matters pertaining to management
      【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
      • 1)Decision on short form merger, short form merger through spin-off, small-scale mergers, and small-scale merger through spin-off
      • 2)Execution and reporting of asset revaluation
      【Other important matters pertaining to the management of the Company】
      • 1)Establishment and revision of basic policies on the management of the Company
    • 3.Matters pertaining to finance
      【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
      • 1)Disposition or redemption of treasury shares
      • 2)Issuance of new shares
      • 3)Issuance of corporate bonds, convertible bonds, or bonds with warrants
      • 4)Capitalization of reserves
      • 5)Allocation of new shares to a 3rd party
      • 6)Distribution of interim dividends
      • 7)Transaction with a “specially-related party” as set forth in the Commercial Code or large-scale transaction for a “specially-related party”
      • 8)Handling of forfeited shares in case of capitalization by issuing new shares
      【Other important matters pertaining to finance】
      • 1)Foreign direct investment valued at 2.5% or more of the equity capital of the Company
      • 2)Listing of shares or depository certificates in a foreign stock exchange
      • 3)Borrowing valued at 2.5% or more of the equity capital of the Company
      • 4)Acquisition or waiver of debt valued at 2.5% or more of the equity capital of the Company per transaction
      • 5)Offering of security or guarantee of debt valued at 2.5% or more of the equity capital of the Company per transaction
      • 6)Donation or sponsorship valued at KRW 100 million or more
      • 7)Other important financial matters to be submitted to the BOD
    • 4.Matters pertaining to directors, the BOD, committees, etc.
      【Mandatory agenda items set forth in the relevant laws/regulations and the AOI】
      • 1)Appointment of the representative director
      • 2)Appointment of the chairperson of the BOD in case the representative director is unable to serve as the chairperson
      • 3)Establishment and operation of a committee(s) within the BOD, appointment and dismissal of a committee member
      • 4)Approval of a director serving as a concurrent director at another company that competes with or operates in the same industry as the Company and approval of transaction between a director, etc., and the Company
      • 5)Re-resolution of an agenda item for resolution by a committee within the BOD
      • 6)Appointment or dismissal of a director from a specific position or duty
      【Other important matters pertaining to directors, the BOD, committees, etc.】
      • 1)Enforcement or nullification of the Rules and Regulations of the Board of Directors or the rules and regulations of committees within the BOD (operational guidelines)
    • 5.Others
      • 1)Other matters set forth in the relevant laws and regulations or the AOI, authorized and delegated by the general meeting of shareholders, or deemed necessary by the representative director
  • The following matters shall be reported to the BOD:
    • 1.Matters that have been delegated to a committee(s) within the BOD and how such matters were decided / resolved
    • 2.Matters for which the Audit Committee has determined that a director has or there is a concern that a director may violate the relevant laws or the AOI
    • 3.Other matters pertaining to the execution of matters that are considered important to the operations of the Company
Article 9Delegation of Authority
  • Unless stipulated otherwise in the relevant laws and regulations or the AOI, the representative director or a committee authorized by the BOD under Article 10 may be delegated with the authority to make decisions on matters that require a resolution of the BOD.
Article 10Committees under BOD
  • Committees within the BOD shall be subject to Article 37 of the AOI; provided, however, that with respect to the Audit Committee, Chapter 6 (Audit Committee) of the AOI shall first apply.
  • The Management Committee shall operate in compliance with the rules and resolutions of the BOD, and in addition, deliberate on and resolve matters delegated by the BOD from time to time.
  • Unless they are in conflict with Paragraph 1 of this Article 10 and the rules of applicable committee within the BOD, Article 38 of the AOI shall apply mutatis mutandis to the committee(s) within the BOD. In such provisions of the AOI, “BOD” shall mean applicable “committee within the BOD” and “Director” shall mean a “member of such committee.”
  • Notwithstanding anything stated in Paragraph 3 of Article 10, matters set forth in Article 397-2 (Restriction on Abuse of Corporate Opportunities and Assets of the Company) and Article 398 (Transactions between Directors, Etc., and the Company) of the Commercial Code shall be adopted by two-thirds or more of the registered directors of the BOD.
Article 11Counsel of Relevant Persons
  • In deliberating on an agenda item, the BOD may invite a relevant officer or employee of the Company or a third party to attend the BOD meeting and explain the agenda item or provide his/her opinion.
  • The BOD may, at the cost of the Company, resolve to engage an expert or other similar individual to consult on a particular agenda item, if it finds such a service necessary.
Article 12Meeting Minutes
  • Meeting minutes shall be prepared for BOD meetings and meetings of any committee within the BOD, and such meeting minutes shall set forth the agenda, proceedings of the meeting, results, objecting party and reason(s) for objection, and be affixed with the seal impressions of or signed by the directors present at the meeting.
Article 13Ratification
  • If an issue is urgent, and there is insufficient time to convene a meeting of the BOD, so long as and to the extent it does not violate the relevant laws and regulations, the representative director shall perform the necessary action and convene a meeting of the BOD after the fact where he/she shall report the progress of such action and obtain the BOD’s ratification.
Article 14Secretary
  • The BOD shall have a secretary who shall be appointed by the chairperson.
  • The chairperson of the BOD shall instruct and supervise the secretary. The secretary shall assist each director of the BOD and administer the overall operations of the BOD.
Article 15Expenses
  • Expenses necessary for meetings and other operations shall be borne by the Company.
Article 16Enactment and Nullification of the Rules
  • These Rules shall be enacted and nullified by a resolution of the BOD.
Addendum
  • Article 1 (Effective Date)
  • These Rules shall become effective on August 10, 2016.

Major Agenda items

1. A director with his or her own interests in a resolution of the board of directors shall not be allowed to participate in voting.

  • Convening of the general meeting of shareholders
  • Approval of financial statements
  • Approval of annual report
  • Amendment to the AOI
  • Dissolution, amalgamation, continuation of company
  • Assignment of the businesses of the company in whole or in material part; acquisition in whole or in part of another company’s business having a material impact on the business of the company.
  • Appointment and dismissal of directors
  • Remuneration of directors, etc.

2. Matters pertaining to management

  • Matters pertaining to management
  • Enforcement or nullification of the Rules and Regulations of the Board of Directors or the rules and regulations of committees within the BOD

3. Matters pertaining to finance

  • Disposition or redemption of treasury shares
  • issuance of new shares
  • Issuance of corporate bonds, convertible bonds, or bonds with warrants
  • Foreign direct investment, borrowing, acquisition or waiver of debt, offering of security or guarantee of debt, etc.
  • Transaction with a “specially-related party” as set forth in the Commercial Code or large-scale transaction for a “specially-related party”, etc.
  • Donation or sponsorship

4. Matters pertaining to directors, the BOD, committees, etc.

  • Appointment of the representative director
  • Appointment of the chairperson of the BOD
  • Approval of a director serving as a concurrent director at another company that competes with or operates in the same industry as the Samsung iologics and approval of transaction between a director, etc., and Samsung Biologics
  • Appoint or dismissal of a director from a specific position or duty

5. Others

  • Other matters set forth in the relevant laws and regulations or the AOI, authorized and delegatedby the general meeting of shareholders, or deemed necessary by the representative director

Activity of the BOD includes the status of the board of directors' activities such as appointment, commissioning, approval, participation, decision, revision, enforcement, reporting and issuance.

2023

2023 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
DEC. 20, 2023 (Reported) 2023 Employee incentive provision plan - 7/7
1. Approval of transactions with major shareholders Approved
2. Approval of transactions with related parties Approved
3. Amendments on operation policy of Board of Directors Approved
4. Appointment of lead independent director Approved
5. Approval of charity donation Approved
6. Nomination of Board of Director's committee members Approved
OCT. 25, 2023 (Reported) 3Q 2023 interim business result - 7/7
1. Approval of purchasing package insurance from Samsung Fire & Marine Insurance Co.,Ltd Approved
2. Approval of New Technology Investment Association Approved
3. Approval of investment in construction of ADC facility Approved
4. Approval of transactions with related parties Approved
5. Appointment of internal compliance auditor Approved
JUL. 26, 2023 (Reported) 1H 2023 interim business result - 7/7
(Reported) Report on increased legal fees and expenses associated with the accounting lawsuit -
1. Approval of transactions with major shareholders Approved
2. Regulation of responsibility and authority for Chief Safety Officer (CSO) Approved
APR. 24, 2023 (Reported) 1Q 2023 interim business result - 7/7
(Reported) 2023 ESG management plan -
1. Approval of transactions with major shareholders Approved
MAR. 17, 2023 (Reported) Progress on important matters - 6/7
(Reported) 2023 health and safety plan -
1. Nomination of Chief Executive Officer Approved
2. Nomination of Board of Director’s chairman Approved
3. Nomination of Board of Director's committeemembers Approved
4. Review of compensation for directors Approved
5. Approval of transactions with related parties Approved
6. Approval of investment for Plant 5 construction Approved
FEB. 15, 2023 (Reported) Operation status of internal control over financial reporting - 5/6
(Reported) Assessment on internal control over financial reporting and audit report -
(Reported) 2022 audit performance report -
1. Approval of amendments to internal control management Approved
2. Approval of convocation and objectives of general meetings of shareholders Approved
JAN. 27, 2023 (Reported) Progress on important matters - 6/6
1. Approval of FY2022 financial statements, annual business report, and 2023 business plan Approved
2. Approval of transactions with related parties Approved
DEC. 20, 2023 Activity of the BOD - Date, Attendance, Agenda, Result
DEC. 20, 2023 Attendance 7/7
Agenda (Reported) 2023 Employee incentive provision plan
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved
Agenda 3. Amendments on operation policy of Board of Directors
Result Approved
Agenda 4. Appointment of lead independent director
Result Approved
Agenda 5. Approval of charity donation
Result Approved
Agenda 6. Nomination of Board of Director's committee members
Result Approved
OCT. 25, 2023 Activity of the BOD - Date, Attendance, Agenda, Result
OCT. 25, 2023 Attendance 7/7
Agenda (Reported) 3Q 2023 interim business result
Result -
Agenda 1. Approval of purchasing package insurance from Samsung Fire & Marine Insurance Co.,Ltd
Result Approved
Agenda 2. Approval of New Technology Investment Association
Result Approved
Agenda 3. Approval of investment in construction of ADC facility
Result Approved
Agenda 4. Approval of transactions with related parties
Result Approved
Agenda 5. Appointment of internal compliance auditor
Result Approved
JUL. 26, 2023 Activity of the BOD - Date, Attendance, Agenda, Result
JUL. 26, 2023 Attendance 7/7
Agenda (Reported) 1H 2023 interim business result
Result -
Agenda (Reported) Report on increased legal fees and expenses associated with the accounting lawsuit
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
Agenda 2. Regulation of responsibility and authority for Chief Safety Officer (CSO)
Result Approved
APR. 24, 2023 Activity of the BOD - Date, Attendance, Agenda, Result
APR. 24, 2023 Attendance 7/7
Agenda (Reported) 1Q 2023 interim business result
Result -
Agenda (Reported) 2023 ESG management plan
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
MAR. 17, 2023 Activity of the BOD - Date, Attendance, Agenda, Result
MAR. 17, 2023 Attendance 6/7
Agenda (Reported) Progress on important matters
Result -
Agenda (Reported) 2023 health and safety plan
Result -
Agenda 1. Nomination of Chief Executive Officer
Result Approved
Agenda 2. Nomination of Board of Director’s chairman
Result Approved
Agenda 3. Nomination of Board of Director's committeemembers
Result Approved
Agenda 4. Review of compensation for directors
Result Approved
Agenda 5. Approval of transactions with related parties
Result Approved
Agenda 6. Approval of investment for Plant 5 construction
Result Approved
FEB. 15, 2023 Activity of the BOD - Date, Attendance, Agenda, Result
FEB. 15, 2023 Attendance 5/6
Agenda (Reported) Operation status of internal control over financial reporting
Result -
Agenda (Reported) Assessment on internal control over financial reporting and audit report
Result -
Agenda (Reported) 2022 audit performance report
Result -
Agenda 1. Approval of amendments to internal control management
Result Approved
Agenda 2. Approval of convocation and objectives of general meetings of shareholders
Result Approved
JAN. 27, 2023 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 27, 2023 Attendance 6/6
Agenda (Reported) Progress on important matters
Result -
Agenda 1. Approval of FY2022 financial statements, annual business report, and 2023 business plan
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved

2022

2022 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
DEC. 21, 2022 (Reported) FY2022 incentive payment plan report - 7/7
1. Approval of transactions with major shareholders Approved
2. Approval of transactions with related parties Approved
NOV. 30, 2022 1. Approval of charitable contributions Approved 7/7
2. Approval of transactions with major shareholders Approved
OCT. 26, 2022 (Reported) Legal services fee for accounting issues litigation - 5/5
OCT. 26, 2022 (Reported) FY2022 3rd quarter earnings report - 7/7
1. Joining a financial instrument of Samsung Fire & Marine Insurance Approved
2. Approval of transactions with major shareholders Approved
3. Approval of anti-corruption guidelines Approved
4. Approval of charitable contributions Approved
5. Amendment to operational regulations of ESG Committee Approved
JUL. 27, 2022 (Reported) FY2022 half year earnings report - 7/7
(Reported) Progress of important matters -
1. Approval of implementation of Anti-bribery management systems (ISO37001) Approved
2. Approval of transactions with major shareholders Approved
3. Approval of transactions with related parties Approved
APR. 27, 2022 (Reported) FY2022 1st quarter earnings report - 7/7
(Reported) Progress of important matters -
1. Approval of transactions with related parties Approved
2. Approval of transactions with major shareholders Approved
MAR. 29, 2022 (Reported) Appointment of members of committees within the BOD Approved 7/7
1. Setting the remuneration of Directors Approved
2. Approval of contract to purchase land for Bio Campus II Approved
3. Approval of 2022 Safety and Health management system Approved
FEB. 25, 2022 (Reported) FY2021 Audit Committee activities - 7/7
(Reported) Operation status of internal accounting management system -
(Reported) Evaluation and audit report of internal accounting management system -
(Reported) FY2021 Audit performance report -
(Reported) Approval of payment of legal services fee for management’s litigation -
(Reported) Assignment of employee stock ownership -
1. Decision to convene the 11th(FY2021) AGM Approved
JAN. 28, 2022 1. Signed stock purchase agreement Approved 7/7
2. Paid-in capital increase Approved
JAN. 27, 2022 1. Cancellation of signed stock purchase agreement and paid-in capital increase resolution Approved 5/7
JAN. 27, 2022 1. Signed stock purchase agreement Approved 7/7
2. Paid-in capital increase Approved
JAN. 24, 2022 (Reported) Report of shareholders' dividend policy - 7/7
1. Approval of FY2021 financial statements and annual business report Approved
2. Approval of transactions with related parties Approved
3. Approval of charitable contribution of idle raw materials Approved
DEC. 21 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
DEC. 21 2022 Attendance 7/7
Agenda (Reported) FY2022 incentive payment plan report
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved
NOV. 30 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
NOV. 30 2022 Attendance 7/7
Agenda 1. Approval of charitable contributions
Result Approved
Agenda 2. Approval of transactions with major shareholders
Result Approved
OCT. 26 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
OCT. 26 2022 Attendance 5/5
Agenda (Reported) Legal services fee for accounting issues litigation
Result -
OCT. 26 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
OCT. 26 2022 Attendance 7/7
Agenda (Reported) FY2022 3rd quarter earnings report
Result -
Agenda 1. Joining a financial instrument of Samsung Fire & Marine Insurance
Result Approved
Agenda 2. Approval of transactions with major shareholders
Result Approved
Agenda 3. Approval of anti-corruption guidelines
Result Approved
Agenda 4. Approval of charitable contributions
Result Approved
Agenda 5. Amendment to operational regulations of ESG Committee
Result Approved
JUL. 27 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 27 2022 Attendance 7/7
Agenda (Reported) FY2022 half year earnings report
Result -
Agenda (Reported) Progress of important matters
Result -
Agenda 1. Approval of implementation of Anti-bribery management systems (ISO37001)
Result Approved
Agenda 2. Approval of transactions with major shareholders
Result Approved
Agenda 3. Approval of transactions with related parties
Result Approved
APR. 27 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
APR. 27 2022 Attendance 7/7
Agenda (Reported) FY2022 1st quarter earnings report
Result -
Agenda (Reported) Progress of important matters
Result -
Agenda 1. Approval of transactions with related parties
Result Approved
Agenda 2. Approval of transactions with major shareholders
Result Approved
MAR. 29, 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
MAR. 29, 2022 Attendance 7/7
Agenda (Reported) Appointment of members of committees within the BOD
Result Approved
Result Approved
Agenda 1. Setting the remuneration of Directors
Result Approved
Agenda 2. Approval of contract to purchase land for Bio Campus II
Result Approved
Agenda 3. Approval of 2022 Safety and Health management system
Result Approved
FEB. 25, 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
FEB. 25, 2022 Attendance 7/7
Agenda (Reported) FY2021 Audit Committee activities
Result -
Agenda (Reported) Operation status of internal accounting management system
Result -
Agenda (Reported) Evaluation and audit report of internal accounting management system
Result -
Agenda (Reported) FY2021 Audit performance report
Result -
Agenda (Reported) Approval of payment of legal services fee for management’s litigation
Result -
Agenda (Reported) Assignment of employee stock ownership
Result -
Agenda 1. Decision to convene the 11th(FY2021) AGM
Result Approved
JAN. 28, 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 28, 2022 Attendance 7/7
Agenda 1. Signed stock purchase agreement
Result Approved
Agenda 2. Paid-in capital increase
Result Approved
JAN. 27, 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 27, 2022 Attendance 5/7
Agenda 1. Cancellation of signed stock purchase agreement and paid-in capital increase resolution
Result Approved
JAN. 27, 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 27, 2022 Attendance 7/7
Agenda 1. Signed stock purchase agreement
Result Approved
Agenda 2. Paid-in capital increase
Result Approved
JAN. 24, 2022 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 24, 2022 Attendance 7/7
Agenda (Reported) Report of shareholders' dividend policy
Result -
Agenda 1. Approval of FY2021 financial statements and annual business report
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved
Agenda 3. Approval of charitable contribution of idle raw materials
Result Approved

2021

2021 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
DEC. 20, 2021 (Reported) FY2021 incentive payment plan report - 7/7
1. Approval of transactions with related parties Approved
2. Approval of transactions with major shareholders Approved
3. Amendment to operational regulations of Related Party Transaction Committee Approved
OCT. 26, 2021 (Reported) FY2021 3rd quarter earnings report - 6/7
1. Approval of transactions with major shareholders Approved
2. Approval of transactions with related parties Approved
3. Approval of charitable contributions Approved
JUL. 27, 2021 (Reported) Legal service fee for management's litigation - 5/5
JUL. 27, 2021 (Reported) FY2021 half year earnings report - 7/7
1. Amendment to operational regulations of Audit Committee Approved
2. Amendment to instructions of internal accounting management Approved
3. Joining new technology investment association Approved
4. Issuance of Corporate bond Approved
5. Approval of 2021 charitable contributions Approved
APR. 28, 2021 (Reported) FY2021 1st quarter earnings report - 7/7
1. Constitution of ESG Committee Approved
MAR. 19, 2021 (Reported) 2021 incentive compensation plan - 7/7
(Reported) Assessment of internal accounting management system by CEO and the Audit committee -
(Reported) Assessment of 2020 compliance review -
1. Approval of 2021 compensation limit for Directiors Approved
2. Approval of transaction with major shareholders Approved
MAR. 19, 2021 1. Approval of payment of legal services fee for management's litigation - 5/7
FEB. 26, 2021 (Reported) Operation status of internal accounting management system - 7/7
(Reported) Evaluation and audit report of internal accounting management system -
1. Payment of Samsung CI License Approved
2. Transaction of Golf Club membership with an affiliate company Approved
3. Amendment to operational regulations of Remuneration Committee Approved
4. Approval of establishment of operation of ESG committee Approved
5. Decision to convene the 10th(FY2020) AGM Approved
6. Adoption of electronic voting system Approved
7. Approval of 2021 Safety and Health management system Approved
FEB. 26, 2021 1. Change of limit on legal services fee for management's litigation Approved 5/7
2. Approval of change of members of Management Committee Approved
JAN. 26, 2021 1. Approval of FY2020 financial statements and annual business report Approved 7/7
2. Approval of operational improvement strategies of Remuneration Committee Approved
3. Approval of concurrent positions of the Chief Executive Officer Approved
JAN. 26, 2021 1. Approval of payment of legal services fee for management's litigation Approved 5/7
DEC. 20, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
DEC. 20, 2021 Attendance 7/7
Agenda (Reported) FY2021 incentive payment plan report
Result -
Agenda 1. Approval of transactions with related parties
Result Approved
Agenda 2. Approval of transactions with major shareholders
Result Approved
Agenda 3. Amendment to operational regulations of Related Party Transaction Committee
Result Approved
OCT. 26, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
OCT. 26, 2021 Attendance 6/7
Agenda (Reported) FY2021 3rd quarter earnings report
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved
Agenda 3. Approval of charitable contributions
Result Approved
JUL. 27, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 27, 2021 Attendance 5/5
Agenda (Reported) Legal service fee for management's litigation
Result -
JUL. 27, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 27, 2021 Attendance 7/7
Agenda (Reported) FY2021 half year earnings report
Result -
Agenda 1. Amendment to operational regulations of Audit Committee
Result Approved
Agenda 2. Amendment to instructions of internal accounting management
Result Approved
Agenda 3. Joining new technology investment association
Result Approved
Agenda 4. Issuance of Corporate bond
Result Approved
Agenda 5. Approval of 2021 charitable contributions
Result Approved
APR. 28, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
APR. 28, 2021 Attendance 7/7
Agenda (Reported) FY2021 1st quarter earnings report
Result -
Agenda 1. Constitution of ESG Committee
Result Approved
MAR. 19, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
MAR. 19, 2021 Attendance 7/7
Agenda (Reported) 2021 incentive compensation plan
Result -
Agenda (Reported) Assessment of internal accounting management system by CEO and the Audit committee
Result -
Agenda (Reported) Assessment of 2020 compliance review
Result -
Agenda 1. Approval of 2021 compensation limit for Directiors
Result Approved
Agenda 2. Approval of transaction with major shareholders
Result Approved
MAR. 19, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
MAR. 19, 2021 Attendance 5/7
Agenda 1. Approval of payment of legal services fee for management's litigation
Result Approved
FEB. 26, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
FEB. 26, 2021 Attendance 7/7
Agenda (Reported) Operation status of internal accounting management system
Result -
Agenda (Reported) Evaluation and audit report of internal accounting management system
Result -
Agenda 1. Payment of Samsung CI License
Result Approved
Agenda 2. Transaction of Golf Club membership with an affiliate company
Result Approved
Agenda 3. Amendment to operational regulations of Remuneration Committee
Result Approved
Agenda 4. Approval of establishment of operation of ESG committee
Result Approved
Agenda 5. Decision to convene the 10th(FY2020) AGM
Result Approved
Agenda 6. Adoption of electronic voting system
Result Approved
Agenda 7. Approval of 2021 Safety and Health management system
Result Approved
FEB. 26, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
FEB. 26, 2021 Attendance 5/7
Agenda 1. Change of limit on legal services fee for management's litigation
Result Approved
Agenda 2. Approval of change of members of Management Committee
Result Approved
JAN. 26, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 26, 2021 Attendance 7/7
Agenda 1. Approval of FY2020 financial statements and annual business report
Result Approved
Agenda 2. Approval of operational improvement strategies of Remuneration Committee
Result Approved
Agenda 3. Approval of concurrent positions of the Chief Executive Officer
Result Approved
JAN. 26, 2021 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 26, 2021 Attendance 5/7
Agenda 1. Approval of payment of legal services fee for management's litigation
Result Approved

2020

2020 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
DEC. 29, 2020 (Reported) Report on operational improvement strategies of Remuneration Committee - 5/7
1. Approval of legal fee payment for a lawsuit against management Approved
2. Amendment to operational regulations of the Board of Directors (Introduction and operation of support staffs) Approved
DEC. 16, 2020 (Reported) FY2021 business plan report - 7/7
(Reported) FY2020 incentive payment plan report -
1. Approval of transactions with major shareholders Approved
2. Approval of transactions with related parties Approved
3. Joining a financial instrument of Samsung Securities Approved
4. Payment of retirement pension Approved
5. Charitable contributions Approved
6. Appointment of Chief Executive Officer Approved
OCT. 21, 2020 (Reported) FY2020 3rd quarter earnings report - 7/7
1. Approval of transactions with major shareholders Approved
2. Approval of transactions with related parties Approved
3. Amendment to operational regulations and instructions of internal accounting management Approved
4. Appointment of compliance manager Approved
SEP. 25, 2020 (Reported) Report on progress regarding prosecution of executive - 7/7
AUG. 11, 2020 1. Approval of investment in Plant 4 Approved 7/7
JUL. 21, 2020 (Reported) FY2020 half year earnings report - 7/7
(Reported) FY2020 1H company's evaluation result -
(Reported) Report on management issue -
(Reported) 2020 July executive appointment Approved
1. Approval of transactions with major shareholder (Samsung Electronics) Approved
2. Joining a financial instrument of Samsung Securities Approved
APR. 20, 2020 (Reported) FY2020 1st quarter earnings report - 7/7
MAR. 20, 2020 (Reported) 2020 incentive payment report - 7/7
(Reported) Report of new facility investment -
1. Appointment of CEO & director Approved
2. Appointment of Chairman of BOD Approved
3. Appointment of members of committees within the BOD Approved
4. Setting the remuneration of directors Approved
5. Approval of large-scale internal transactions Approved
FEB. 28, 2020 (Reported) Reporting the operation status of internal accounting management system - 5/5
(Reported) Evaluation and audit report of the internal accounting management system -
(Reported) Evaluation and report of compliance -
(Reported) Report of major facility supplementary investment -
1. Decision to convene the 9th (FY2019) AGM Approved
JAN. 22, 2020 1. Approval of FY2019 financial statements and annual business report Approved 5/5
JAN. 10, 2020 1. Approval of the establishment of a foreign corporation in the U.S. Approved 5/5
DEC. 29, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
DEC. 29, 2020 Attendance 5/7
Agenda (Reported) Report on operational improvement strategies of Remuneration Committee
Result -
Agenda 1. Approval of legal fee payment for a lawsuit against management
Result Approved
Agenda 2. Amendment to operational regulations of the Board of Directors (Introduction and operation of support staffs)
Result Approved
DEC. 16, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
DEC. 16, 2020 Attendance 7/7
Agenda (Reported) FY2021 business plan report
Result -
Agenda (Reported) FY2020 incentive payment plan report
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved
Agenda 3. Joining a financial instrument of Samsung Securities
Result Approved
Agenda 4. Payment of retirement pension
Result Approved
Agenda 5. Charitable contributions
Result Approved
Agenda 6. Appointment of Chief Executive Officer
Result Approved
OCT. 21, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
OCT. 21, 2020 Attendance 7/7
Agenda (Reported) FY2020 3rd quarter earnings report
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved
Agenda 3. Amendment to operational regulations and instructions of internal accounting management
Result Approved
Agenda 4. Appointment of compliance manager
Result Approved
SEP. 25, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
SEP. 25, 2020 Attendance 7/7
Agenda (Reported) Report on progress regarding prosecution of executive
Result -
AUG. 11, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
AUG. 11, 2020 Attendance 7/7
Agenda 1. Approval of investment in Plant 4
Result Approved
JUL. 21, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 21, 2020 Attendance 7/7
Agenda (Reported) FY2020 half year earnings report
Result -
Agenda (Reported) FY2020 1H company's evaluation result
Result -
Agenda (Reported) Report on management issue
Result -
Agenda (Reported) 2020 July executive appointment
Result -
Agenda 1. Approval of transactions with major shareholder (Samsung Electronics)
Result Approved
Agenda 2. Joining a financial instrument of Samsung Securities
Result Approved
APR. 20, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
APR. 20, 2020 Attendance 7/7
Agenda (Reported) FY2020 1st quarter earnings report
Result -
MAR. 20, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
MAR. 20, 2020 Attendance 7/7
Agenda (Reported) 2020 incentive payment report
Result -
Agenda (Reported) Report of new facility investment
Result -
Agenda 1. Appointment of CEO & director
Result Approved
Agenda 2. Appointment of Chairman of BOD
Result Approved
Agenda 3. Appointment of members of committees within the BOD
Result Approved
Agenda 4. Setting the remuneration of directors
Result Approved
Agenda 5. Approval of large-scale internal transactions
Result Approved
FEB. 28, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
FEB. 28, 2020 Attendance 5/5
Agenda (Reported) Reporting the operation status of internal accounting management system
Result -
Agenda (Reported) Evaluation and audit report of the internal accounting management system
Result -
Agenda (Reported) Evaluation and report of compliance
Result -
Agenda (Reported) Report of major facility supplementary investment
Result -
Agenda 1. Decision to convene the 9th (FY2019) AGM
Result Approved
JAN. 22, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 22, 2020 Attendance 5/5
Agenda 1. Approval of FY2019 financial statements and annual business report
Result Approved
JAN. 11, 2020 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 11, 2020 Attendance 5/5
Agenda 1. Approval of the establishment of a foreign corporation in the U.S.
Result Approved

2019

2019 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
DEC. 16, 2019 (Reported) FY2019 Incentive payment status - 5/5
1. Approval of transactions with major shareholder Approved
2. Approval of transactions with related parties Approved
3. Joining a financial instrument of Samsung Securities Approved
4. Payment of retirement pension Approved
OCT. 23, 2019 (Reported) FY2019 3Q earnings report - 5/5
SEP. 11, 2019 (Reported) Discussions on the creation of a support organization in the Audit Committee - 5/5
JUL. 23, 2019 (Reported) FY2019 half year earnings report - 5/5
1. Approval of FY2018 financial statements corrections -
APR. 24, 2019 (Reported) FY2019 1st quarter earnings report - 5/5
1. Approval of transactions with related parties Approved
MAR. 22, 2019 1. Appointment of members of committees within the BOD Approved 5/5
2. Setting the remuneration of directors Approved
3. Joining a financial instrument of Samsung Securities Approved
4. Approval of transactions with related parties Approved
FEB. 27, 2019 (Report) Reporting the operation status of internal accounting management system - 5/5
(Report) Evaluation and audit report of the internal accounting management system -
(Report) 2019 Incentive Payment Report -
(Report) Evaluation and report of 2018 Compliance -
1. Decision to convene the 8th(FY2018) AGM -
JAN. 31, 2019 1. Approval of FY2018 financial statements and annual business report - 5/5
2. Approval of revision of the operation regulations of audit committee Approved
3. Approval of revision of internal accounting control system regulations Approved
4. Addition of New Business Place Approved
5. Approval of transactions with major shareholders Approved
DEC. 16, 2019 Activity of the BOD - Date, Attendance, Agenda, Result,
DEC. 16, 2019 Attendance 5/5
Agenda (Reported) FY2019 Incentive payment status
Result -
Agenda 1. Approval of transactions with major shareholder
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved
Agenda 3. Joining a financial instrument of Samsung Securities
Result Approved
Agenda 4. Payment of retirement pension
Result Approved
OCT. 23, 2019 Activity of the BOD - Date, Attendance, Agenda, Result,
OCT. 23, 2019 Attendance 5/5
Agenda (Reported) FY2019 3Q earnings report
SEP. 11, 2019 Activity of the BOD - Date, Attendance, Agenda, Result,
SEP. 11, 2019 Attendance 5/5
Agenda (Reported) Discussions on the creation of a support organization in the Audit Committee
Result -
JUL. 23, 2019 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 23, 2019 Attendance 5/5
Agenda (Reported) FY2019 half year earnings report
Result -
Agenda 1. Approval of FY2018 financial statements corrections
Result -
APR. 24, 2019 Activity of the BOD - Date, Attendance, Agenda, Result,
APR. 24, 2019 Attendance 5/5
Agenda (Reported) FY2019 1st quarter earnings report
Result -
Agenda 1. Approval of transactions with related parties
Result Approved
MAR. 22, 2019 Activity of the BOD - Date, Attendance, Agenda, Result,
MAR. 22, 2019 Attendance 5/5
Agenda 1. Appointment of members of committees within the BOD
Result Approved
Agenda 2. Setting the remuneration of directors
Result Approved
Agenda 3. Joining a financial instrument of Samsung Securities
Result Approved
Agenda 4. Approval of transactions with related parties
Result Approved
FEB. 27, 2019 Activity of the BOD - Date, Attendance, Agenda, Result,
FEB. 27, 2019 Attendance 5/5
Agenda (Report) Reporting the operation status of internal accounting management system
Result -
Agenda (Report) Evaluation and audit report of the internal accounting management system
Result -
Agenda (Report) 2019 Incentive Payment Report
Result -
Agenda (Report) Evaluation and report of 2018 Compliance
Result -
Agenda 1. Decision to convene the 8th(FY2018) AGM
Result Approved
JAN. 31, 2019 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 31, 2019 Attendance 5/5
Agenda 1. Approval of FY2018 financial statements and annual business report
Result Approved
Agenda 2. Approval of revision of the operation regulations of audit committee
Result Approved
Agenda 3. Approval of revision of internal accounting control system regulations
Result Approved
Agenda 4. Addition of New Business Place
Result Approved
Agenda 5. Approval of transactions with major shareholders
Result Approved

2018

2018 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
DEC. 24, 2018 1. Approval of transactions with major shareholders Approved 5/5
2. Approval of transactions with related parties Approved
3. Payment of retirement pension Approved
4. Revision of the in-house trade committee’s operation provisions Approved
OCT. 23, 2018 (Reported Item) FY2018 3rd quarter earnings report - 5/5
1. Time deposits of Samsung Securities Co., Ltd. Approved
2. Investments in subsidiaries Approved
OCT. 04, 2018 (Reported Item) Report on Major Management Issues - 5/5
JUL. 23, 2018 (Reported Item) FY2018 1st half year earnings report - 5/5
JUN. 28, 2018 (Reported Item) Report on Major Management Issues - 5/5
APR. 24, 2018 (Reported Item) FY2018 1st quarter earnings report - 5/5
1. Issue of Corporate bond Approved
2. Approval of trading with controlling shareholder Approved
MAR. 22, 2018 1. Setting the remuneration of directors Approved 5/5
FEB. 28, 2018 (Reported Item) Report on the internal accounting management system - 5/5
1. Approval of FY2017 financial statements and annual business report Approved
2. Decision to convene the 7th(FY2017) AGM Approved
JAN. 31, 2018 (Reported Item) Performance bonus of FY2017 for key objectives - 5/5
1. Approval of FY2017 financial statements and annual business report Approved
2. Revision of the operation regulations of the independent director referral committee Approved
DEC. 24, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
DEC. 24, 2018 Attendance 5/5
Agenda 1. Approval of transactions with major shareholders
Result Approved
Agenda 2. Approval of transactions with related parties
Result Approved
Agenda 3. Payment of retirement pension
Result Approved
Agenda 4. Revision of the in-house trade committee’s operation provisions
Result Approved
OCT. 23, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
OCT. 23, 2018 Attendance 5/5
Agenda (Reported Item) FY2018 3rd quarter earnings report
Result -
Agenda 1. Time deposits of Samsung Securities Co., Ltd.
Result Approved
Agenda 2. Investments in subsidiaries
Result Approved
OCT. 04, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
OCT. 04, 2018 Attendance 5/5
Agenda (Reported Item) Report on Major Management Issues
Result -
JUL. 23, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 23, 2018 Attendance 5/5
Agenda (Reported Item) FY2018 1st half year earnings report
Result -
JUN. 28, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 28, 2018 Attendance 5/5
Agenda (Reported Item) Report on Major Management Issues
Result -
APR. 24, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
APR. 24, 2018 Attendance 5/5
Agenda (Reported Item) FY2018 1st quarter earnings report
Result -
Agenda 1. Issue of Corporate bond
Result Approved
Agenda 2. Approval of trading with controlling shareholder
Result Approved
MAR. 22, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
MAR. 22, 2018 Attendance 5/5
Agenda 1. Setting the remuneration of directors
Result Approved
FEB. 28, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
FEB. 28, 2018 Attendance 5/5
Agenda (Reported Item) Report on the internal accounting management system
Result -
Agenda 1. Approval of FY2017 financial statements and annual business report
Result Approved
Agenda 2. Decision to convene the 7th(FY2017) AGM
Result Approved
JAN. 31, 2018 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 31, 2018 Attendance 5/5
Agenda (Reported Item) Performance bonus of FY2017 for key objectives
Result -
Agenda 1. Approval of FY2017 financial statements and annual business report
Result Approved
Agenda 2. Revision of the operation regulations of the independent director referral committee
Result Approved

2017

2017 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
JUL. 24, 2017 Report on financial results concerning 2Q/2017 - 5/5
1. Approval of transactions with major shareholders Approved
JUL. 30, 2017 Report on result of corporate appraisal of the company in the first half of 2017 - 5/5
MAY. 18, 2017 Report on status of operation of the company’s evaluation/remuneration system - 5/5
1. Approval of transactions with major shareholders Approved
APR. 25, 2017 Report on financial results concerning 1Q/2017 - 5/5
MAR. 24, 2017 1. Election of the representative director and entrustment of business to directors Approved 5/5
2. Appointment of the chairperson of the board of directors Approved
3. Appointment of members of the committees of the board of directors Approved
4. Execution of limit of directors’ remuneration Approved
5. Revision of the rules and regulations of the board of directors Approved
FEB. 27, 2017 1. Convening of the general meeting of shareholders and decision on purpose of the meeting Approved 5/5
2. Approval of transactions with major shareholders Approved
JAN. 24, 2017 1. Convening of the general meeting of shareholders and decision on purpose of the meeting Approved 5/5
JUL. 24, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 24, 2017 Attendance 5/5
Agenda Report on financial results concerning 2Q/2017
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
JUL. 30, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
JUL. 30, 2017 Attendance 5/5
Agenda Report on result of corporate appraisal of the company in the first half of 2017
Result -
MAY. 18, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
MAY. 18, 2017 Attendance 5/5
Agenda Report on status of operation of the company’s evaluation/remuneration system
Result -
Agenda 1. Approval of transactions with major shareholders
Result Approved
APR. 25, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
APR. 25, 2017 Attendance 5/5
Agenda Report on financial results concerning 1Q/2017
Result -
MAR. 24, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
MAR. 24, 2017 Attendance 5/5
Agenda 1. Election of the representative director and entrustment of business to directors
Result Approved
Agenda 2. Appointment of the chairperson of the board of directors
Result Approved
Agenda 3. Appointment of members of the committees of the board of directors
Result Approved
Agenda 4. Execution of limit of directors’ remuneration
Result Approved
Agenda 5. Revision of the rules and regulations of the board of directors
Result Approved
FEB. 27, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
FEB. 27, 2017 Attendance 5/5
Agenda 1. Convening of the general meeting of shareholders and decision on purpose of the meeting
Result Approved
Agenda 2. Approval of transactions with major shareholders
Result Approved
JAN. 24, 2017 Activity of the BOD - Date, Attendance, Agenda, Result,
JAN. 24, 2017 Attendance 5/5
Agenda 1. Convening of the general meeting of shareholders and decision on purpose of the meeting
Result Approved

2016

2016 Activity of the BOD - Date, Agenda, Result, Attendance
Date Agenda Result Attendance
DEC. 13, 2016 1. Participation in Samsung Bioepis’ capital increase Approved 5/5
2. Participation in Archigen’s capital increase Approved
3. Approval of transactions with major shareholders Approved
4. Approval of transactions with specially related parties Approved
5. Subscription to retirement pension Approved
SEP. 29, 2016 1. Approval for issuance of new shares for IPO and for sales of old shares Approved 5/5
2. Approval of internal trading with specially related parties Approved
AUG. 10, 2016 1. Appointment of the chairperson of the board of directors Approved 5/5
2. Entrusting business to directors Approved
3. Appointment of the members of the committees of the board of directors Approved
4. Appointment of the compliance officer Approved
5. Appointment of the transfer agent Approved
DEC. 13, 2016 Activity of the BOD - Date, Attendance, Agenda, Result,
DEC. 13, 2016 Attendance 5/5
Agenda 1. Participation in Samsung Bioepis’ capital increase
Result Approved
Agenda 2. Participation in Archigen’s capital increase
Result Approved
Agenda 3. Approval of transactions with major shareholders
Result Approved
Agenda 4. Approval of transactions with specially related parties
Result Approved
Agenda 5. Subscription to retirement pension
Result Approved
SEP. 29, 2016 Activity of the BOD - Date, Attendance, Agenda, Result,
SEP. 29, 2016 Attendance 5/5
Agenda 1. Approval for issuance of new shares for IPO and for sales of old shares
Result Approved
Agenda 2. Approval of internal trading with specially related parties
Result Approved
AUG. 10, 2016 Activity of the BOD - Date, Attendance, Agenda, Result,
AUG. 10, 2016 Attendance 5/5
Agenda 1. Appointment of the chairperson of the board of directors
Result Approved
Agenda 2. Entrusting business to directors
Result Approved
Agenda 3. Appointment of the members of the committees of the board of directors
Result Approved
Agenda 4. Appointment of the compliance officer
Result Approved
Agenda 5. Appointment of the transfer agent
Result Approved

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION